vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $35.3M, roughly 1.3× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -23.3%, a 67.2% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs 7.0%). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.

AMRN vs UNTY — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.3× larger
AMRN
$45.1M
$35.3M
UNTY
Growing faster (revenue YoY)
UNTY
UNTY
+17.2% gap
UNTY
24.2%
7.0%
AMRN
Higher net margin
UNTY
UNTY
67.2% more per $
UNTY
43.9%
-23.3%
AMRN
Faster 2-yr revenue CAGR
UNTY
UNTY
Annualised
UNTY
17.5%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
UNTY
UNTY
Revenue
$45.1M
$35.3M
Net Profit
$-10.5M
$15.5M
Gross Margin
Operating Margin
35.5%
55.8%
Net Margin
-23.3%
43.9%
Revenue YoY
7.0%
24.2%
Net Profit YoY
33.0%
34.5%
EPS (diluted)
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
UNTY
UNTY
Q1 26
$45.1M
Q4 25
$49.2M
$35.3M
Q3 25
$49.7M
$32.8M
Q2 25
$72.7M
$34.4M
Q1 25
$42.0M
$29.4M
Q4 24
$62.3M
$28.4M
Q3 24
$42.3M
$27.7M
Q2 24
$67.5M
$25.5M
Net Profit
AMRN
AMRN
UNTY
UNTY
Q1 26
$-10.5M
Q4 25
$-1.2M
$15.5M
Q3 25
$-7.7M
$14.4M
Q2 25
$-14.1M
$16.5M
Q1 25
$-15.7M
$11.6M
Q4 24
$-48.6M
$11.5M
Q3 24
$-25.1M
$10.9M
Q2 24
$1.5M
$9.5M
Gross Margin
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
UNTY
UNTY
Q1 26
35.5%
Q4 25
-12.9%
55.8%
Q3 25
-22.4%
57.5%
Q2 25
-22.0%
62.6%
Q1 25
-39.9%
52.6%
Q4 24
-84.3%
51.0%
Q3 24
-59.5%
52.7%
Q2 24
-0.8%
49.3%
Net Margin
AMRN
AMRN
UNTY
UNTY
Q1 26
-23.3%
Q4 25
-2.5%
43.9%
Q3 25
-15.6%
43.8%
Q2 25
-19.4%
48.0%
Q1 25
-37.4%
39.5%
Q4 24
-78.0%
40.5%
Q3 24
-59.4%
39.4%
Q2 24
2.3%
37.1%
EPS (diluted)
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
$0.00
$1.52
Q3 25
$-0.02
$1.41
Q2 25
$-0.03
$1.61
Q1 25
$-0.04
$1.13
Q4 24
$-0.12
$1.13
Q3 24
$-0.06
$1.07
Q2 24
$0.00
$0.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
UNTY
UNTY
Cash + ST InvestmentsLiquidity on hand
$307.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$345.6M
Total Assets
$645.8M
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
UNTY
UNTY
Q1 26
$307.8M
Q4 25
$302.6M
Q3 25
$286.6M
Q2 25
$298.7M
Q1 25
$281.8M
Q4 24
$294.2M
Q3 24
$305.7M
Q2 24
$306.7M
Total Debt
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$230.8M
Q3 24
Q2 24
Stockholders' Equity
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
$459.3M
$345.6M
Q3 25
$458.9M
$334.0M
Q2 25
$464.9M
$319.8M
Q1 25
$473.7M
$306.1M
Q4 24
$486.2M
$295.6M
Q3 24
$531.4M
$284.3M
Q2 24
$551.9M
$273.4M
Total Assets
AMRN
AMRN
UNTY
UNTY
Q1 26
$645.8M
Q4 25
$670.8M
$3.0B
Q3 25
$659.8M
$2.9B
Q2 25
$670.1M
$2.9B
Q1 25
$655.7M
$2.8B
Q4 24
$685.3M
$2.7B
Q3 24
$750.6M
$2.6B
Q2 24
$799.9M
$2.6B
Debt / Equity
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.78×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
UNTY
UNTY
Operating Cash FlowLast quarter
$44.9M
Free Cash FlowOCF − Capex
$44.3M
FCF MarginFCF / Revenue
125.7%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
2.90×
TTM Free Cash FlowTrailing 4 quarters
$81.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
$15.3M
$44.9M
Q3 25
$-12.7M
$45.5M
Q2 25
$16.6M
$-25.3M
Q1 25
$-12.5M
$17.9M
Q4 24
$-13.3M
$48.0M
Q3 24
$-2.4M
$17.7M
Q2 24
$-2.7M
$-8.4M
Free Cash Flow
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
$44.3M
Q3 25
$45.3M
Q2 25
$-25.5M
Q1 25
$17.6M
Q4 24
$47.3M
Q3 24
$17.5M
Q2 24
$-8.6M
FCF Margin
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
125.7%
Q3 25
138.1%
Q2 25
-74.2%
Q1 25
59.9%
Q4 24
166.5%
Q3 24
63.3%
Q2 24
-33.7%
Capex Intensity
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
1.6%
Q3 25
0.7%
Q2 25
0.5%
Q1 25
1.0%
Q4 24
2.4%
Q3 24
0.5%
Q2 24
0.5%
Cash Conversion
AMRN
AMRN
UNTY
UNTY
Q1 26
Q4 25
2.90×
Q3 25
3.16×
Q2 25
-1.54×
Q1 25
1.54×
Q4 24
4.17×
Q3 24
1.62×
Q2 24
-1.81×
-0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

UNTY
UNTY

Segment breakdown not available.

Related Comparisons